☆ 4.3 Article

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer

Oncotarget (2019)

Get Full Text
Add to Collection

Journal

Oncotarget
Volume 10, Issue 38, Pages -

Publisher

Impact Journals, LLC
DOI: 10.18632/oncotarget.26960

Keywords

-

Categories

-

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.